09 Sep 2015
Good growth in H1, M&A needed to take to next level
Interim results show good growth and should be well received this morning. Branded Distributed was the star segment and it is pleasing to see market share gains for LiquiBand in the US. Investment is being made to support the Branded Direct sales activities where growth has been a little sluggish. Overall, no change to our forecasts at this stage. We see deployment of the group’s firepower via M&A as being the next major catalyst for the shares, but there is nothing to report as yet. We stay at ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good growth in H1, M&A needed to take to next level
Advanced Medical Solutions Group plc (AMS:LON) | 192 3.5 0.9% | Mkt Cap: 418.2m
- Published:
09 Sep 2015 -
Author:
Chris Glasper -
Pages:
3
Interim results show good growth and should be well received this morning. Branded Distributed was the star segment and it is pleasing to see market share gains for LiquiBand in the US. Investment is being made to support the Branded Direct sales activities where growth has been a little sluggish. Overall, no change to our forecasts at this stage. We see deployment of the group’s firepower via M&A as being the next major catalyst for the shares, but there is nothing to report as yet. We stay at ....